Home
>
US Stocks
>
Deciphera Pharmaceuticals Inc
Deciphera Pharmaceuticals Inc
DCPH

Deciphera Pharmaceuticals Inc (DCPH)

$34.5817.22%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
34.13
Today Low/High
33.03 / 34.58
52 Week Low/High
$26.71 / $68.4
Market Cap
$1.63B

Company Details

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. The Company is leveraging its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from its platform in clinical studies, QINLOCK is Deciphera's FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Canada and Australia.
Organisation
Deciphera Pharmaceuticals Inc
Headquaters
Waltham, Massachusetts, United States
Employees
350
Industry
Health Technology
CEO
Steven Hoerter

Discover more

Frequently Asked Questions

What is Deciphera Pharmaceuticals Inc (DCPH) share price today?

Can Indians buy Deciphera Pharmaceuticals Inc (DCPH) shares?

How can I buy Deciphera Pharmaceuticals Inc (DCPH) shares from India?

Can Fractional shares of Deciphera Pharmaceuticals Inc (DCPH) be purchased?

What are the documents required to start investing in Deciphera Pharmaceuticals Inc (DCPH) stocks?

We are a SEBI registered investement advisor